ADTRAN Holdings Inc
F:QH9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ADTRAN Holdings Inc
F:QH9
|
US |
|
Elicera Therapeutics AB
F:8E8
|
SE |
Wall St Price Targets
QH9 Price Targets Summary
ADTRAN Holdings Inc
According to Wall Street analysts, the average 1-year price target for QH9 is 18.21 EUR with a low forecast of 16.7 EUR and a high forecast of 22.19 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is QH9's stock price target?
Price Target
18.21
EUR
According to Wall Street analysts, the average 1-year price target for QH9 is 18.21 EUR with a low forecast of 16.7 EUR and a high forecast of 22.19 EUR.
What is the Revenue forecast for ADTRAN Holdings Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 10%.
What is the Gross Profit forecast for ADTRAN Holdings Inc?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 3 years is 15%.
